A University of Massachusetts researcher has established a new statistical tool that holds potential for improving the treatment of AIDS in developing countries.
Andrea Foulkes, head of the Biostatistics program in the school of public health and health sciences at the University of Massachusetts, and her colleagues propose a prediction-based classification (PBC) model that would prioritize the initiation of antiretroviral therapy for AIDS patients based on their CD-4 T-cell count.
